Milano - 13 October 2017


Palazzo Lombardia, Milano

The 536/14 regulation, aimed to increase the number of clinical trials and to support and facilitate the Sponsors in trial start up and conduction, is planned to be implemented in Europe soon (expected within 2019). In the meanwhile, the clinical research environment is rapidly evolving due to new technologies, big data collection, new drugs, precision medicine, advanced therapies, development of new methodology and clinical trial design (e.g. basket and umbrella trials).
This international meeting is aimed to discuss and evaluate whether the new EU Regulation will effectively improve the European competitiveness and how it will be implemented in different European countries. International and national speakers (competent authorities, clinical researchers, EU and extra EU sponsors, CROs, institutions, academic sponsors and patients) will discuss about this key topic.